Privium Fund Management’s Novartis NVS Stock Holding History

Privium Fund Management’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-6,000	Closed	-$580K	–	134
2024 Q1	$580K	Sell	6,000 -3,980	-40%	-$408K	0.16%	57
2023 Q4	$1.01M	Sell	9,980 -1,000	-9%	-$96.5K	0.28%	40
2023 Q3	$1.12M	Sell	10,980 -2,270	-17%	-$230K	0.33%	42
2023 Q2	$1.32M	Hold	13,250	–	–	0.38%	42
2023 Q1	$1.22M	Buy	13,250 +2,000	+18%	+$175K	0.41%	36
2022 Q4	$1.03M	Hold	11,250	–	–	0.39%	35
2022 Q3	$861K	Buy	+11,250	New	+$933K	0.31%	48

Other funds holding NVS

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

CCM

Cullen Capital Management New York $10.2B AUM 27.15% 1-Year Est. Return

Privium Fund Management's NVS Position: Q2 2024 in Review

Privium Fund Management sold out of Novartis (NVS) in Q2 2024, closing a stake of 6,000 shares — an estimated $580K sold.

Privium Fund Management first reported a position in NVS in Q3 2022 and held it in 7 quarters. The position peaked at $1.32M in Q2 2023. 1,307 funds tracked by Wall St. Rank hold NVS as of Q2 2024.

Privium Fund Management reported no remaining Novartis position as of Q2 2024 after selling out during the quarter.
Privium Fund Management sold 6,000 Novartis shares in Q2 2024, an estimated $580K.
Privium Fund Management first reported a position in Novartis in Q3 2022 and held it in 7 quarters.
Privium Fund Management's Novartis position peaked at $1.32M in Q2 2023.
1,307 funds tracked by Wall St. Rank held Novartis as of Q2 2024.

Based on Privium Fund Management's 13F filing for Q2 2024, filed 1 Aug 2024.